|1.||Ueda, K: 2 articles (03/2001 - 03/2000)|
|2.||Yamanishi, K: 2 articles (03/2001 - 03/2000)|
|3.||Okuno, T: 2 articles (03/2001 - 03/2000)|
|4.||Chen, J: 2 articles (03/2001 - 03/2000)|
|5.||DeMaster, Laura K: 1 article (01/2014)|
|6.||Rose, Timothy M: 1 article (01/2014)|
|7.||Ganem, Don: 1 article (06/2003)|
|8.||Bechtel, Jill T: 1 article (06/2003)|
|9.||Hvidding, Joshua: 1 article (06/2003)|
|10.||Liang, Yuying: 1 article (06/2003)|
01/05/2014 - "Our studies suggest that RRV lacks the Rta-inducible LANA promoter that is responsible for LANA inhibition of the KSHV Rta promoter and induction of latency during KSHV infection. "
06/01/2003 - "These results indicate (i) that the host cell receptor(s) and entry machinery for KSHV are widely distributed on cultured adherent cells, (ii) that latency is the default pathway of infection, and (iii) that blocks to lytic induction are frequent and largely reside at or upstream of the expression of KSHV RTA."
12/20/1998 - "Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein."
06/05/2002 - "HIV gene expression activated the KSHV Rta promoter following viral infection or after transfection of proviral DNA. "
|2.||Contagious Ecthyma (Orf)
06/01/1997 - "Identification of a cis-acting element within the herpesvirus saimiri ORF 6 promoter that is responsive to the HVS.R transactivator."
03/27/2001 - "KSHV Lyta (lytic transactivator, also named KSHV/Rta), mainly encoded by the ORF 50 gene, is a lytic switch gene for viral reactivation from latency, inasmuch as it is both essential and sufficient to drive the entire viral lytic cycle. "
03/01/2000 - "Transient-transfection assays showed that the K5 promoter was transactivated by ORF 50 (KSHV Rta), a homolog of Epstein-Barr virus Rta, but the K5 gene product exhibited no transregulation of its own promoter or those of DNA polymerase and the human immunodeficiency virus type 1 long terminal repeat. "
|1.||DNA (Deoxyribonucleic Acid)
|2.||Trans-Activators (Trans-Acting Factor)